ANI Pharmaceuticals Inc (ANIP) Common Stock USD0.0001
Sell:$60.60Buy:$108.55
$1.08
(1.56%)
0.13%- This stock can be held in a
Stocks and Shares ISA$1.08
(1.56%)$1.08
(1.56%)Company Information
About this company
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company engaged in developing, manufacturing, and commercializing therapeutics. Its Rare Disease and Brands segment consists of two reporting units. The Rare Disease unit consists of operations related to the development, manufacturing, and marketing of branded pharmaceutical products, with a focus on products used in the treatment of patients with rare disease conditions and consists of operations related to Cortrophin Gel, ILUVIEN and YUTIQ. In addition, the Brands reporting unit includes a portfolio of over 16 brand products that are principally sold in genericized markets. Its Generics and Other segment consist of operations related to the development, manufacturing, and marketing of generic pharmaceutical products, including those sold through traditional wholesale and retail sales channels, sales of contract manufactured products, royalties on contract manufactured products, product development services, and others.
Key people
Key facts
- EPICANIP
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINUS00182C1036
- Market cap$1.49bn
- Employees897
- Shares in issue22.03m
- ExchangeNASDAQ
- IndexS&P 600 Small Cap, TR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.